SCHEMBL2595460

SCHEMBL2595460

CC(C)(C)OC(=O)N(CCc1ccc(N)cc1)Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.51
HDAC3 O15379 2/20 0.51
HDAC2 Q92769 2/20 0.51
NCOR2 Q9Y618 2/20 0.51
HDAC6 Q9UBN7 1/20 0.49
RCE1 Q9Y256 1/20 0.49
LPAR1 Q92633 3/20 0.45
LPAR5 Q9H1C0 3/20 0.45
CA12 O43570 6/20 0.44
CA1 P00915 6/20 0.44
CA2 P00918 6/20 0.44
CA4 P22748 3/20 0.44
MAOB P27338 3/20 0.44
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
MAOA P21397 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27540555 1.00 HDAC1 (0.51) HDAC1HDAC3HDAC2NCOR2HDAC6
SCHEMBL16682328 0.95 ADRB3 (0.44) HDAC1HDAC3HDAC2NCOR2HDAC6
SCHEMBL579680 0.94 LPAR1 (0.54) HDAC1HDAC3HDAC2NCOR2HDAC6
SCHEMBL18067948 0.92 ADRB3 (0.42) HDAC1HDAC3HDAC2NCOR2HDAC6
SCHEMBL9823156 0.92 HDAC1 (0.54) HDAC1HDAC3HDAC2NCOR2HDAC6
SCHEMBL3151994 0.91 HDAC3 (0.59) HDAC1HDAC3HDAC2NCOR2MAOB
SCHEMBL3695642 0.88 HDAC1 (0.55) HDAC1HDAC3HDAC2NCOR2HDAC6
SCHEMBL580233 0.88 HDAC1 (0.55) HDAC1HDAC3HDAC2NCOR2HDAC6
SCHEMBL1798901 0.88 HDAC1 (0.52) HDAC1HDAC3HDAC2NCOR2HDAC6
SCHEMBL18067962 0.88 HDAC3 (0.46) HDAC1HDAC3HDAC2NCOR2CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569290-A2 PHARMACEUTICAL COMPOUNDS Sentinel Oncology Limited (GB) 2013-03-20 EP disclosed
WO-2011141716-A2 PHARMACEUTICAL COMPOUNDS SENTINEL ONCOLOGY LIMITED (GB) 2011-11-17 WO disclosed